Pancreatic cancer oxygenation as a prognostic marker during anticancer therapy
2022/45/B/NZ5/01695
Keywords
Descriptors
- NZ4_002: Fizjologia
- NZ5_007: Leczenie chorób człowieka
- NZ7_014: Farmacja, farmakoterapia, farmakologia
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 6
Call
OPUS 23 – announced on 2022-03-28
- Amount awarded
- 2 863 143 PLN
- Project start date
- 2023-01-23
- Project end date
- 2028-01-22
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Pulse and CW EPR Oximetry Using Oxychip in Gemcitabine-Treated Murine Pancreatic Tumors
- Authors:
- Gabriela Dziurman, Agnieszka Drzał, Aleksandra Anna Murzyn, Maciej Mikolaj Kmiec, Martyna Elas & Martyna Krzykawska-Serda
- Academic press:
- Molecular Imaging and Biology (year: 2023, volume: 26, pages: 473–483), Publisher: Springer
- Status:
- Published
- DOI:
- 10.1007/s11307-023-01859-w – link to the publication